A Study of Lasmiditan in Healthy Japanese and Caucasian Participants

NCT03579940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lasmiditan
DRUG: Placebo

Sponsor

Eli Lilly and Company